Clinical Trials Logo
  1. Home
  2. Infection
  3. NCT02217046
  4. Details
NCT02217046 Clinical Trial

Decrease Implantation Site INFECTION : a Randomized Controlled Trial

Infection Clinical Trial

Official title:
Phase 1 Study of Prevention of Cardiac Device Replacement Site Infection

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT02217046
Other study ID # DISINFECTION II
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date December 2013
Est. completion date October 2025

Study information
Verified date April 2019
Source Seoul St. Mary's Hospital
Contact Yong Seog Oh, Ph.D
Phone 82-10-7101-3810
Email oys@catholic.ac.kr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Cardiovascular implantable electronic device (CIED) infections have been increasing out of proportion to the number of devices implanted the investigators investigated recent trends and possible causes of the increasing numbers of Cardiovascular implantable electronic device infections.

Description:

There are many studies on the preventive use of Antibiotics or povidone iodine to Cardiovascular implantable electronic device (CIED) infections.

But, studies of posterior pocket capsule removal is still limited.

The investigators had planned research on effects of posterior pocket capsule removal before cardiac devices replacement.

Recruitment information / eligibility
Status Recruiting
Enrollment 352
Est. completion date October 2025
Est. primary completion date August 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- scheduled for cardiac devices replacement

Exclusion Criteria:

- under the age of 18

- take an antibiotic

- history of infection within 30 days

Study Design

Related Conditions & MeSH terms

Intervention

Procedure:
• device replacement(pocket capsule removal)
remove previously inserted cardiac device and posterior pocket capsule. the pocket that will receive the heart mechanism is sterilized with a hydroperoxide soaked gauze

Locations
Country Name City State
Korea, Republic of Seoul St Mary's Hospital Seoul Seo Ch-gu

Sponsors (1)
Lead Sponsor Collaborator
Yong Seog Oh

Country where clinical trial is conducted

Korea, Republic of, 

Outcome
Type Measure Description Time frame Safety issue
Other freedom of general infection check the symptoms of infection. If have symptoms of infection : check the fever, heart rate, respiration rate, blood test, EKG 1 year after procedure
Primary freedom of cardiac device-related infection check the symptoms of infection. If have symptoms of infection : check the fever, heart rate, respiration rate, blood test, EKG 1 year after precedure
Secondary freedom of endocarditis check the symptoms of infection. If have symptoms of infection : check the fever, heart rate, respiration rate, blood test, EKG 1 year after precedure
See also
  Status Clinical Trial Phase
Completed NCT04529421 - Assocation Between In-person Instruction and COVID-19 Risk
Recruiting NCT04081792 - Optimal Antibiotics for Operated Diabetic Foot Infections N/A
Completed NCT04332861 - Evaluation of Infection in Obstructing Urolithiasis
Recruiting NCT04674657 - Does Extra-Corporeal Membrane Oxygenation Alter Antiinfectives Therapy Pharmacokinetics in Critically Ill Patients
Enrolling by invitation NCT05052203 - Researching the Effects of Sepsis on Quality Of Life, Vitality, Epigenome and Gene Expression During RecoverY From Sepsis
Recruiting NCT00342589 - New Techniques for Using a Saline Wash as a Diagnostic Tool for Pneumocystis Pneumonia
Completed NCT03295825 - Heparin Binding Protein in Early Sepsis Diagnosis N/A
Completed NCT03296423 - Bacillus Calmette-guérin Vaccination to Prevent Infections of the Elderly Phase 4
Withdrawn NCT04217252 - Clinical Application of High-throughput Sequencing Technology for the Diagnosis of Patients With Severe Infection N/A
Recruiting NCT02905552 - Myelodysplasic Syndromes and Risk Factors for Infection N/A
Recruiting NCT02899143 - Short-course Antimicrobial Therapy in Sepsis Phase 2
Withdrawn NCT02904434 - Gastrointestinal Implications of Voriconazole Exposure
Active, not recruiting NCT02768454 - Antimicrobials Stewardship by Pharmacist N/A
Completed NCT02219776 - Decreasing Infection In Arthroscopic Shoulder Surgery N/A
Completed NCT02210169 - RCT of Continuous Versus Intermittent Infusion of Vancomycin in Neonates N/A
Recruiting NCT02098226 - Evaluation of MALDI Biotyper CA System for Detection of Gram- and Gram+ Bacteria and Yeasts N/A
Completed NCT01846832 - A Study of TMC435 Plus Pegylated Interferon Alfa-2a and Ribavirin in Participants With Chronic HCV Infection Phase 3
Terminated NCT01441206 - Safety and Pharmacokinetics of Single and Multiple Dose Rifampin in Infants Phase 1
Completed NCT01434797 - Value of PET/CT Imaging in the Diagnosis of Permanent Central Venous Catheters Infection
Completed NCT01159834 - Human Papillomavirus (HPV) Vaccination in Barretos (Pio XII Foundation - Barretos Cancer Hospital) N/A